You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.


We determine the safety and feasibility of magnetic resonance image guided transurethral ultrasound prostate ablation using active temperature feedback control in a preclinical canine model with 28-day followup.

Materials and Methods:

After a long acclimatization period we performed ultrasound treatment in 8 subjects using the magnetic resonance image guided TULSA-PRO™ transurethral ultrasound prostate ablation system. Comprehensive examinations and observations were done before and throughout the 28-day followup, including assessment of clinically significant treatment related adverse events. In addition to gross pathology evaluation, extensive histopathological analysis was done to assess cell kill inside and outside the prostate. We evaluated prostate conformal heating by comparing the spatial difference between the treatment plan and the 55C isotherm measured on magnetic resonance imaging thermometry acquired during treatment. These findings were confirmed on contrast enhanced magnetic resonance imaging immediately after treatment and at 28 days.


Clinically there were no adverse events in any of the 8 subjects throughout the 28-day followup. All subjects had normal urinary and bowel function. Gross necropsy and histology confirmed that the intended thermal cell kill was confined to the prostate. No surrounding tissue was damaged, including the rectum and the external urinary sphincter. Conformal heating was achieved with an average −0.9 mm accuracy and 0.9 mm precision. Contrast enhanced magnetic resonance imaging and histological analysis confirmed tissue ablation in targeted areas of the prostate. Urethral tissue was spared from thermal damage.


Magnetic resonance image guided transurethral ultrasound is a safe, feasible procedure for accurate and precise conformal thermal ablation of prostate tissue, as demonstrated in a preclinical model with 28-day followup.


  • 1 : Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer2010; 127: 2893. Google Scholar
  • 2 : Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst2004; 96: 1358. Google Scholar
  • 3 : Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol2007; 177: 2106. LinkGoogle Scholar
  • 4 : The changing face of prostate cancer. J Clin Oncol2005; 23: 8146. Google Scholar
  • 5 : The changing age distribution of prostate cancer in Canada. Can J Public Health2007; 98: 60. Google Scholar
  • 6 : MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. Radiology2012; 265: 303. Google Scholar
  • 7 : The development of intracavitary ultrasonic applicators for hyperthermia: a design and experimental study. Med Phys1990; 17: 626. Google Scholar
  • 8 : Feasibility of a transurethral ultrasound applicator for coagulation in prostate. Ultrasound Med Biol2004; 30: 113. Google Scholar
  • 9 : Highly directional transurethral ultrasound applicators with rotational control for MRI-guided prostatic thermal therapy. Phys Med Biol2004; 49: 189. Google Scholar
  • 10 : MRI-compatible transurethral ultrasound system for the treatment of localized prostate cancer using rotational control. Med Phys2008; 35: 1346. Google Scholar
  • 11 : Quantitative analysis of 3-D conformal MRI-guided transurethral ultrasound therapy of the prostate: theoretical simulations. Int J Hyperthermia2009; 25: 116. Google Scholar
  • 12 : Simulation study on the heating of the surrounding anatomy during transurethral ultrasound prostate therapy: a 3D theoretical analysis of patient safety. Med Phys2010; 37: 2862. Google Scholar
  • 13 : Transurethral ultrasound applicators with directional heating patterns for prostate thermal therapy: in vivo evaluation using magnetic resonance thermometry. Med Phys2004; 31: 405. Google Scholar
  • 14 : Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback. Phys Med Biol2009; 54: 2615. Google Scholar
  • 15 : MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies. Urology2010; 76: 1506. Google Scholar
  • 16 : Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customized MRI-based moulds. BJU Int2013; 112: 508. Google Scholar
  • 17 : Applicators for magnetic resonance-guided ultrasonic ablation of benign prostatic hyperplasia. Invest Radiol2013; 48: 387. Google Scholar
  • 18 : Prostate tissue analysis immediately following magnetic resonance imaging guided transurethral ultrasound thermal therapy. J Urol2007; 178: 1080. LinkGoogle Scholar
  • 19 : Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys1984; 10: 787. Google Scholar
  • 20 : A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med1995; 34: 814. Google Scholar
  • 21 : Measures of the amount of ecologic association between species. Ecology1945; 26: 297. Google Scholar
  • 22 : Quantitative comparison of thermal dose models in normal canine brain. Med Phys2010; 37: 5313. Google Scholar
  • 23 : Magnetic resonance imaging tissue classification using a partial volume model. Neuroimage2001; 13: 856. Google Scholar
  • 24 : 3D conformal MRI-controlled transurethral ultrasound prostate therapy: validation of numerical simulations and demonstration in tissue-mimicking gel phantoms. Phys Med Biol2010; 55: 6817. Google Scholar
  • 25 : Histotripsy of the prostate using a commercial system in a canine model. J Urol2014; 191: 860. LinkGoogle Scholar
  • 26 : MP62-05 Magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation of prostate cancer: preliminary outcomes of a phase I clinical trial. J Urol2014; 191: e718. LinkGoogle Scholar
  • 27 : Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. International Task Force on Prostate Cancer and the Focal Lesion Paradigm. J Urol2007; 178: 2260. LinkGoogle Scholar